Showing results (1-10 of 552) with videos related to
Sort By:
Pageof 56
Neurotoxicology|May 31, 2011
β-Hexachlorocyclohexane levels in serum and risk of Parkinson's diseaseJason R Richardson, Ananya Roy, Stuart L Shalat, et al.JAMA Neurology|January 30, 2014
Elevated serum pesticide levels and risk for Alzheimer diseaseJason R Richardson, Ananya Roy, Stuart L Shalat, et al.Archives of Neurology|July 15, 2009
Elevated serum pesticide levels and risk of Parkinson diseaseJason R Richardson, Stuart L Shalat, Brian Buckley, et al.Handbook of Clinical Neurology|May 8, 2025
CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatmentAbraham Fisher, Allan I LeveyExperimental Neurology|February 8, 2012
Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's diseasePatricia K Sonsalla, Lai-Yoong Wong, Suzan L Harris, et al.Experimental Neurology|November 5, 2013
The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonismPatricia K Sonsalla, Christal Coleman, Lai-Yoong Wong, et al.Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
Alzheimer's disease: A clinical perspective and future nonhuman primate research opportunitiesRafi U Haque, Allan I LeveyScience (New York, N.Y.)|December 14, 2023
Immunotherapies for Alzheimer's diseaseTodd E Golde, Allan I LeveyProgress in Brain Research|December 4, 2003
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampusLaura A Volpicelli, Allan I LeveyThe Journal of Comparative Neurology|May 12, 2021
Mapping reward mechanisms by intracerebral self-stimulation in the rhesus monkey (Macaca mulatta)Douglas M Bowden, Dwight C GermanPageof 56